
Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9686605
[patent_doc_number] => 20140243370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'Pyrano[3,2-D][1,3]thiazole as glycosidase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/131471
[patent_app_country] => US
[patent_app_date] => 2012-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29668
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131471
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/131471 | Pyrano [3,2-D][1,3]thiazole as glycosidase inhibitors | Aug 21, 2012 | Issued |
Array
(
[id] => 9643227
[patent_doc_number] => 20140221339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'Heterocyclic Derivative and Pharmaceutical Drug'
[patent_app_type] => utility
[patent_app_number] => 14/238749
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46260
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238749
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238749 | Heterocyclic derivative and pharmaceutical drug | Aug 16, 2012 | Issued |
Array
(
[id] => 10975475
[patent_doc_number] => 20140378510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'SMALL MOLECULE ACTIVATORS OF CALCIUM-ACTIVATED CHLORIDE CHANNELS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/237079
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21528
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237079
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237079 | Small molecule activators of calcium-activated chloride channels and methods of use | Aug 2, 2012 | Issued |
Array
(
[id] => 11177919
[patent_doc_number] => 09409904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Compounds and compositions for use in augmentation of glucose'
[patent_app_type] => utility
[patent_app_number] => 14/236224
[patent_app_country] => US
[patent_app_date] => 2012-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 14077
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236224
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236224 | Compounds and compositions for use in augmentation of glucose | Jul 31, 2012 | Issued |
Array
(
[id] => 9227656
[patent_doc_number] => 08633324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Denibulin di-hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 13/560785
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 8341
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560785 | Denibulin di-hydrochloride | Jul 26, 2012 | Issued |
Array
(
[id] => 8760306
[patent_doc_number] => 08420828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/547501
[patent_app_country] => US
[patent_app_date] => 2012-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27902
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13547501
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/547501 | Inhibitors | Jul 11, 2012 | Issued |
Array
(
[id] => 8477807
[patent_doc_number] => 20120277215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/540113
[patent_app_country] => US
[patent_app_date] => 2012-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52680
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540113
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/540113 | Organic Compounds | Jul 1, 2012 | Abandoned |
Array
(
[id] => 8565994
[patent_doc_number] => 20120328565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/528920
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20039
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528920
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/528920 | ANTIVIRAL COMPOUNDS | Jun 20, 2012 | Abandoned |
Array
(
[id] => 9409121
[patent_doc_number] => 20140100373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/123381
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19349
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123381
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123381 | Production method of imidazole derivatives | Jun 13, 2012 | Issued |
Array
(
[id] => 8660170
[patent_doc_number] => 20130040999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'NEW COMPOUNDS FOR ALLEVIATION, PREVENTION OR TREATMENT OF OSTEOPOROSIS, THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/523612
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11215
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523612
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/523612 | Compounds for alleviation, prevention or treatment of osteoporosis, the preparation thereof and pharmaceutical composition comprising the same | Jun 13, 2012 | Issued |
Array
(
[id] => 8406542
[patent_doc_number] => 20120238611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'DUAL-ACTING BENZOIMIDAZOLE ANTIHYPERTENSIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/483399
[patent_app_country] => US
[patent_app_date] => 2012-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36101
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13483399
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/483399 | Dual-acting benzoimidazole antihypertensive agents | May 29, 2012 | Issued |
Array
(
[id] => 9355579
[patent_doc_number] => 08674112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Polymorph of a pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 13/480882
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6359
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13480882
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/480882 | Polymorph of a pharmaceutical | May 24, 2012 | Issued |
Array
(
[id] => 9450213
[patent_doc_number] => 20140121384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'PROCESS FOR BENDAMUSTINE HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 14/127425
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1685
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127425
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127425 | Process for bendamustine hydrochloride | May 23, 2012 | Issued |
Array
(
[id] => 8503161
[patent_doc_number] => 20120302569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 13/479395
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 39263
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/479395 | PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION | May 23, 2012 | Abandoned |
Array
(
[id] => 8876069
[patent_doc_number] => 08471035
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-06-25
[patent_title] => 'Two-photon absorbing arylamine-endcapped and dialkylfluorene-bridged benzobisthiazole compounds with high oleophilicity'
[patent_app_type] => utility
[patent_app_number] => 13/475159
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9369
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475159 | Two-photon absorbing arylamine-endcapped and dialkylfluorene-bridged benzobisthiazole compounds with high oleophilicity | May 17, 2012 | Issued |
Array
(
[id] => 10013854
[patent_doc_number] => 09056862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Thioxothiazolidine derivative having Ras function inhibitory effect'
[patent_app_type] => utility
[patent_app_number] => 14/116152
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32481
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116152
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116152 | Thioxothiazolidine derivative having Ras function inhibitory effect | May 8, 2012 | Issued |
Array
(
[id] => 8477870
[patent_doc_number] => 20120277277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal'
[patent_app_type] => utility
[patent_app_number] => 13/463487
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29197
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463487
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463487 | Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal | May 2, 2012 | Issued |
Array
(
[id] => 11767852
[patent_doc_number] => 09376427
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Process for preparing rivaroxaban using intermediates'
[patent_app_type] => utility
[patent_app_number] => 14/397551
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4120
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397551
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397551 | Process for preparing rivaroxaban using intermediates | May 1, 2012 | Issued |
Array
(
[id] => 9869443
[patent_doc_number] => 08957215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Heteroaryl substituted benzothiazoles'
[patent_app_type] => utility
[patent_app_number] => 13/453579
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 34766
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/453579 | Heteroaryl substituted benzothiazoles | Apr 22, 2012 | Issued |
Array
(
[id] => 8431173
[patent_doc_number] => 20120253047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'PROCESS FOR THE PREPARATION OF (R)-PRAMIPEXOLE'
[patent_app_type] => utility
[patent_app_number] => 13/450803
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8120
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450803
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450803 | PROCESS FOR THE PREPARATION OF (R)-PRAMIPEXOLE | Apr 18, 2012 | Abandoned |